Anti-T-Cell Globulins Flop in Unrelated Stem Cell Transplants – MedPage Today
|
Anti-T-Cell Globulins Flop in Unrelated Stem Cell Transplants
MedPage Today Acute leukemia or myelodysplastic syndrome patients who received ATLG before myeloablative human leukocyte antigen (HLA)-matched unrelated stem cell transplants had poorer estimated 2-year progression-free survival (47% versus 65%, P=0.04) and overall … |
